TickerFacts.

Guardant Health, Inc. (GH): Gross Profit

Revenue minus cost of revenue for the same annual period and currency, computed by TickerFacts from the filed figures. The issuer may report gross profit or margin on a different basis.

Computed by TickerFacts from revenue minus cost of revenue. This may differ from the issuer's reported gross profit or margin; check the revenue and cost definitions.

$633.01M
Year ended 2025-12-31
$769.16M
Trailing 12 months to 2026-06-30
2023-12-31: $336.90M2024-12-31: $449.22M2025-12-31: $633.01M$633.01M
2023-12-31 Gross Profit (USD) 2025-12-31
Period endedGross ProfitChange YoYSource filing
2025-12-31$633.01M+40.9%2026-02-19, From 2025-01-01
2024-12-31$449.22M+33.3%2026-02-19, From 2024-01-01
2023-12-31$336.90Mn/a2026-02-19, From 2023-01-01

Gross Profit at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedGross ProfitChange YoY
Guardant Health, Inc. (GH)2025-12-31$633.01M+40.9%
Veracyte, Inc. (VCYT)2025-12-31$362.53M+21.6%
Castle Biosciences Inc (CSTL)2025-12-31$273.20M+0.5%
Fulgent Genetics, Inc. (FLGT)2025-12-31$130.88M+22.1%
BillionToOne, Inc. (BLLN)2025-12-31$208.46M+157.6%
Quest Diagnostics Inc (DGX)2025-12-31$3.67B+13.0%
Personalis, Inc. (PSNL)2025-12-31$15.78M-41.2%
Labcorp Holdings Inc. (LH)2025-12-31$4.01B+10.7%
Exagen Inc. (XGN)2025-12-31$38.80M+17.2%

Compare GH, VCYT, CSTL, FLGT side by side · Screen every company in Services-Medical Laboratories ↗